Last reviewed · How we verify
illuccix 68Ga-PSMA-11 Total Body PET-CT — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
illuccix 68Ga-PSMA-11 Total Body PET-CT (illuccix 68Ga-PSMA-11 Total Body PET-CT) — BAMF Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| illuccix 68Ga-PSMA-11 Total Body PET-CT TARGET | illuccix 68Ga-PSMA-11 Total Body PET-CT | BAMF Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- illuccix 68Ga-PSMA-11 Total Body PET-CT CI watch — RSS
- illuccix 68Ga-PSMA-11 Total Body PET-CT CI watch — Atom
- illuccix 68Ga-PSMA-11 Total Body PET-CT CI watch — JSON
- illuccix 68Ga-PSMA-11 Total Body PET-CT alone — RSS
Cite this brief
Drug Landscape (2026). illuccix 68Ga-PSMA-11 Total Body PET-CT — Competitive Intelligence Brief. https://druglandscape.com/ci/illuccix-68ga-psma-11-total-body-pet-ct. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab